NEW YORK (GenomeWeb News) - Fluxion Biosciences said today that it has signed an exclusive agreement with Westburg under which the Leusden, Netherlands-based firm will market its BioFlux live cell image analysis platform in Belgium, the Netherlands, Luxembourg, Denmark, Finland, Iceland, Norway, and Sweden.
 
San Francisco-based Fluxion’s BioFlux 200 system is a microfluidic-based platform designed for live cell imaging in applications such as cell adhesion and microbial biofilm studies.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.